Dr. Robert McWilliams, MD
Claim this profileMayo Clinic in Rochester
Area of expertise
Pancreatic Cancer
Robert McWilliams, MD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Melanoma
Robert McWilliams, MD has run 3 trials for Melanoma. Some of their research focus areas include:
Affiliated Hospitals
Mayo Clinic In Rochester
Mayo Clinic
Clinical Trials Robert McWilliams, MD is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting
0 awards
Phase 2
32 criteria
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting
1 award
Phase 2
9 criteria
More about Robert McWilliams, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Robert McWilliams, MD has experience with
- Nivolumab
- Olaparib
- Niraparib
- Dostarlimab
- RP1
- JSI-1187
Breakdown of trials Robert McWilliams, MD has run
Pancreatic Cancer
Melanoma
Cancer
Colorectal polyposis syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert McWilliams, MD specialize in?
Robert McWilliams, MD focuses on Pancreatic Cancer and Melanoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Robert McWilliams, MD currently recruiting for clinical trials?
Yes, Robert McWilliams, MD is currently recruiting for 4 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Robert McWilliams, MD has studied deeply?
Yes, Robert McWilliams, MD has studied treatments such as Nivolumab, Olaparib, Niraparib.
What is the best way to schedule an appointment with Robert McWilliams, MD?
Apply for one of the trials that Robert McWilliams, MD is conducting.
What is the office address of Robert McWilliams, MD?
The office of Robert McWilliams, MD is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.